APC and cancer: An overview of the top somatic mutations (mutation frequency >5%) in all tumors revealed highly recurrent mutations in TP53 (n = 296, 71% of all patients), APC (n = 141, 34%), and KRAS (n = 137, 33%), and the mutation frequencies vary greatly between different cancers (Figure 1A).